• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, February 25, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researcher gets $2.94 million federal grant to study unique features of Ebola and marburg viruses

Bioengineer by Bioengineer
July 15, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Georgia State University

ATLANTA–Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.

“The planned work will help us understand why these viruses are able to cause severe disease and will suggest new approaches for treating these infections,” said Basler, a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis.

Ebola virus and Marburg virus, which belong to the filovirus family, cause periodic outbreaks and severe disease in humans. The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will fund studies that will provide new insight into interactions between filoviruses and hosts related to translation for gene expression and innate immune evasion.

Despite their importance as emerging pathogens and public health threats, many biological aspects of filoviruses remain unknown. One major knowledge gap is the function of the non-protein coding sequences in filovirus genomes, which compose nearly a quarter of the Ebola and Marburg virus genomes and have barely been studied.

Ebola and Marburg viruses are RNA viral pathogens, and it’s unclear which mechanisms are used to translate viral mRNAs to proteins and how this may be sustained when innate immune responses are activated.

###

View an abstract of the grant, 1R01AI148663-01A1, at the NIH’s Project ReRORTer website.

Media Contact
LaTina Emerson
[email protected]

Original Source

https://news.gsu.edu/2020/07/15/biomedical-sciences-researcher-gets-2-94-million-federal-grant-to-study-unique-features-of-ebola-and-marburg-viruses/

Tags: GenesImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

CAR T-cell therapy generates lasting remissions in patients with multiple myeloma

February 24, 2021
IMAGE

Bearded seals are loud — but not loud enough

February 24, 2021

Study finds human-caused North Atlantic right whale deaths are being undercounted

February 24, 2021

Researchers use machine learning to identify autism blood biomarkers

February 24, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    637 shares
    Share 255 Tweet 159
  • People living with HIV face premature heart disease and barriers to care

    81 shares
    Share 32 Tweet 20
  • Global analysis suggests COVID-19 is seasonal

    37 shares
    Share 15 Tweet 9
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

BiologycancerChemistry/Physics/Materials SciencesMedicine/HealthTechnology/Engineering/Computer ScienceMaterialsGeneticsEcology/EnvironmentPublic HealthClimate ChangeInfectious/Emerging DiseasesCell Biology

Recent Posts

  • Chimpanzees and humans share overlapping territories
  • Allergy season starts earlier each year due to climate change and pollen transport
  • A-maze-ing pheasants have two ways of navigating
  • UM scientists achieve breakthrough in culturing corals and sea anemones cells
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In